Sugi Predict

Sugi Predict / Compounds / SCHEMBL30569680

SCHEMBL30569680

SCHEMBL30569680

N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CS)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 14/20 0.47
▸ FNTB P49356 14/20 0.47
▸ PGGT1B P53609 13/20 0.47
▸ NPY4R P50391 6/20 0.45
▸ NPY1R P25929 4/20 0.45
▸ NPY2R P49146 2/20 0.45
▸ NPY5R Q15761 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23857930 1.00 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL29749040 1.00 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL31723823 1.00 FNTA (0.47) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL29658155 0.97 FNTA (0.46) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL30531616 0.97 FNTA (0.49) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL4302043 0.97 FNTA (0.49) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL31723891 0.96 NPY4R (0.45) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL31723855 0.96 NPY4R (0.45) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL31723920 0.96 NPY4R (0.45) FNTAFNTBPGGT1BNPY4RNPY1R
SCHEMBL31723816 0.96 NPY4R (0.45) FNTAFNTBPGGT1BNPY4RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11781106-B1 Intracellular non-genetic modification of microorganisms using protein ionic liquids UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) 2023-10-10 — — US disclosed
US-20230285594-A1 COMPLEXATION OF NUCLEIC ACIDS WITH DISULFIDE-CROSSLINKED CATIONIC COMPONENTS FOR TRANSFECTION AND IMMUNOSTIMULATION CureVac SE (DE) 2023-09-14 — — US disclosed